Navigation Links
MicuRx Pharmaceuticals Selects Next-Generation Antibiotic Candidate Targeting MRSA and Expands Operation in China
Date:8/18/2008

UNION CITY, Calif. and SHANGHAI, China, Aug. 18 /PRNewswire-FirstCall/ -- MicuRx Pharmaceuticals, Inc., a privately-held biopharmaceutical company developing next-generation antibiotics, today announced the nomination of MRX- I as its first preclinical development candidate. MRX-I is an antibacterial molecule targeting multi-drug resistant gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). Simultaneously, the company expanded its operations in China to increase MicuRx' capacity in antibacterial drug discovery and development.

"Only 12 months after initial funding, we have discovered multiple drug leads and selected our first development candidate MRX-I, a promising antibacterial compound that we expect to be superior to many of the top- selling antibiotics available today," said Zhengyu Yuan, Ph.D., president and chief executive officer of MicuRx Pharmaceuticals, Inc. "This enhanced productivity is owed in part to our hybrid business model that leverages the drug discovery capacity readily available in China and the superior management expertise in the United States."

"MRX-I and additional MicuRx pipeline leads have been identified using our proprietary drug discovery platform," commented Mike F. Gordeev, Ph.D., executive vice president and chief scientific officer of MicuRx. "We will continue to leverage this novel platform to further enhance the pharmacological properties and safety profile of clinically validated antibiotic classes, creating best-in-class antibiotics capable of addressing the growing problem of the bacterial multi-drug resistance."

MicuRx raised $10 million in 2007 with Morningside Group as the sole investor. To facilitate the development of its lead compounds and expand the research capacity, MicuRx recently moved its research and development operations in China to a new 10,000 square-foot facility in ZhangJian HighTech Park in Shanghai, China. The company intends to use this integra
'/>"/>

SOURCE MicuRx Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Lotus Pharmaceuticals Announces Second Quarter 2008 Results
2. XTL Biopharmaceuticals Receives Notice of Non-Compliance with Nasdaq Marketplace Rule Due to Changes in Board Composition
3. Indevus Pharmaceuticals Announces Issuance of U.S. Patent for SANCTURA XR(TM)
4. Access Pharmaceuticals to Present at the Noble Financial Equity Conference
5. Anthera Pharmaceuticals Completes $19 Million Financing; Appoints Christopher S. Henney as Chairman
6. VIA Pharmaceuticals to Present at Fourth Annual Noble Financial Equity Conference
7. Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 Study of MM-121, an ErbB3 Antagonist
8. ADVENTRX Pharmaceuticals to Report Second Quarter 2008 Results
9. SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008
10. ISTA Pharmaceuticals Reports Second Quarter 2008 Financial Results
11. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2008 Financial Results on Monday, August 11, at 8:30 A.M. EDT
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... ... August 03, 2015 , ... The synthetic ... to get such derivatives as ethylbenzene, a precursor to styrene, used to make ... automotive industry for the production of tyres and other components. Thus, growth in ...
(Date:8/3/2015)... -- E-QURE Corp. (OTCQB: EQUR), a Delaware ... Therapy device ("BST Device"), a new and novel electrotherapy ... wounds, today announced that the Company has signed its ... in medical devices, for the marketing and distribution of ... years old, sales, marketing and distribution company in ...
(Date:8/3/2015)... ... August 03, 2015 , ... Sterlitech Corporation ... its comprehensive line of analytical laboratory equipment. With optimized features, such as PTFE-coated ... a chemically resistant and maintenance-free solution for a broad range of vacuum filtration ...
(Date:7/31/2015)... ... July 31, 2015 , ... ... and quantification of partially hydrolyzed gluten in foods, has been accepted by AOAC ... method “Partially Hydrolyzed Gluten in Fermented Cereal-Based Products by R5 Competitive ELISA,” based ...
Breaking Biology Technology:World Benzene Market to Surpass 46 MMT by 2020, According to TechSci Research Report Published at MarketPublishers.com 2World Benzene Market to Surpass 46 MMT by 2020, According to TechSci Research Report Published at MarketPublishers.com 3E-QURE Corp Signs Second Distribution Agreement in Israel 2E-QURE Corp Signs Second Distribution Agreement in Israel 3Sterlitech Launches New Line of Vacuum Pumps 2RIDASCREEN® Competitve Gliadin Receives AOAC Official First Action Status 2
... other multi-resistant organisms, PRINCETON, N.J., May 2 ... of advanced wound care products, today,announced that the ... of top wound,care studies, devoted a section to ... The article, "Spotlighting the Top-10,Research Findings in Wound ...
... Finesse Solutions, LLC,Santa Clara, CA, a manufacturer of ... announced the release of TruViu(TM),PLSS, a vessel utility ... The PLSS package expands on the RDPD system ... enclosures. TruViu(TM) PLSS,consists of an I/O tower, a ...
... May 1 Masimo Corporation,(Nasdaq: MASI ), the ... is scheduled to present at the Deutsche Bank 33rd,Annual ... MA,on Tuesday, May 6, 2008 at 9:30 a.m. ET. ... Web cast of the presentation will be available on ...
Cached Biology Technology:Skin & Aging Article Finds Derma Sciences MEDIHONEY(TM) Helps to Promote Healing Where Antibiotics Fail 2Skin & Aging Article Finds Derma Sciences MEDIHONEY(TM) Helps to Promote Healing Where Antibiotics Fail 3Skin & Aging Article Finds Derma Sciences MEDIHONEY(TM) Helps to Promote Healing Where Antibiotics Fail 4Finesse Solutions Introduces the TruViu(TM) PLSS System 2Masimo to Present at Deutsche Bank 33rd Annual Health Care Conference 2
(Date:7/2/2015)... 2015 Research and ... the "Natural Language Processing Market by Type ... Pattern & Image Recognition) - Worldwide Forecast to ... The key vendors occupying the market are 3M, ... Corporation, NetBase Solutions, SAS Institute Inc., Verint Systems ...
(Date:7/2/2015)... July 2, 2015 Fingerprint Cards has ... FPC1145 and FPC1155 from the distributor World Peace Industrial Group ... distributors in Asia . Deliveries are planned ... will be used by smartphone manufacturers in Asia ... in the communicated revenue guidance of approximately 2,200 MSEK for ...
(Date:6/30/2015)... 2015 Genisphere announced Tom ... help further develop Genisphere,s therapeutics capabilities and portfolio. Mr. ... spent much of the last 25 years in leadership ... and Johnson & Johnson. Tom started his career in ... Corporate Finance. He graduated from Dartmouth College with a ...
Breaking Biology News(10 mins):Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020 2FPC Receives Order for Touch Fingerprint Sensors of 268 MSEK 2Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3
... of Medicine report in a new study that they have ... myelin, the fatty insulation around nerve cells that ensures swift ... in the September 1, 2005, issue of the journal Neuron, ... such as multiple sclerosis, which are associated with damage to ...
... University of Delaware researchers are opening a new front ... nanotechnologies for cancer detection and treatment and introducing a ... tumors. , Balaji Panchapakesan, assistant professor of electrical ... the discoveries in the journals NanoBiotechnology and Oncology Issues. ...
... the January 2006 issue of Nature Biotechnology, researchers led ... Center have devised a novel strategy that uses stem ... sickle cell disease (SCD) in human cells. This research ... correct this debilitating blood disease using RNA interference technology. ...
Cached Biology News:Scientists discover the molecular switch for nerve cells' insulating jelly rolls 2University of Delaware researchers develop cancer 'nanobomb' 2University of Delaware researchers develop cancer 'nanobomb' 3University of Delaware researchers develop cancer 'nanobomb' 4Sickle cell disease corrected in human models using stem cell-based gene therapy 2
... foil heat sealing material is suitable ... a screw down heated lid), especially ... useful method for sample retrieval. Multiple ... existing seal. Ideal for compound management ...
...
...
... fully automated solution for cell culture ... for cell-line maintenance, expansion, harvesting and ... built upon standard, industry proven components: ... configuration capable of both rapid bulk ...
Biology Products: